No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas
Crossref DOI link: https://doi.org/10.1007/s00415-017-8717-3
Published Online: 2017-12-22
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Trillsch, Fabian
Eichhorn, Peter
Oliveira-Ferrer, Leticia
Kuempfel, Tania
Burges, Alexander
Mahner, Sven
Havla, Joachim https://orcid.org/0000-0002-4386-1340
License valid from 2017-12-22